Related Experiment Video

Updated: May 14, 2026

Establishment of the Dual Humanized TK-NOG Mouse Model for HIV-associated Liver Pathogenesis
10:12

Establishment of the Dual Humanized TK-NOG Mouse Model for HIV-associated Liver Pathogenesis

Published on: September 11, 2019

Effect of HIV on liver fibrosis among HCV-infected African Americans

D Silver1, G Karnik, A Osinusi

  • 1Critical Care MedicineDepartment, National Institutes of Health, 1101 Highland Dr, Silver Spring, MD 20910, USA. dana.r.silver@gmail.com

Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|February 5, 2013
PubMed

Insights

Nearly half of patients with hepatitis C virus (HCV) showed early liver fibrosis, even with long-term infection. Human immunodeficiency virus (HIV) coinfection was linked to earlier fibrosis, suggesting some patients may wait for improved HCV treatments.

Area of Science:

  • Hepatology
  • Virology
  • Immunology

Background:

  • Liver fibrosis severity is crucial for determining treatment timing in hepatitis C virus (HCV) patients.
  • Understanding fibrosis progression in diverse populations, including African Americans with HCV monoinfection and human immunodeficiency virus (HIV)/HCV coinfection, is essential.

Purpose of the Study:

  • To investigate liver fibrosis stages and associated predictive factors in African Americans with HCV monoinfection and HIV/HCV coinfection.
  • To assess the potential for delaying treatment in certain patient groups based on fibrosis stage.

Main Methods:

  • Retrospective analysis of patient data.
  • Evaluation of liver fibrosis staging.
  • Identification of factors predicting fibrosis stage, including HIV coinfection status.

Main Results:

  • Approximately 50% of the study cohort presented with early-stage liver fibrosis.
  • Early-stage fibrosis was observed despite long durations of HCV infection in many participants.
  • Human immunodeficiency virus (HIV) coinfection was significantly associated with the early fibrosis group.

Conclusions:

  • A substantial proportion of patients with HCV infection, including those coinfected with HIV, may not require immediate treatment.
  • These findings suggest that some patients could benefit from awaiting the availability of more effective and better-tolerated HCV therapies.
  • Further research into fibrosis progression and treatment strategies in coinfected populations is warranted.

More Related Videos

Mouse Model of Metabolic Dysfunction-Associated Steatotic Liver Disease with Fibrosis06:26

Mouse Model of Metabolic Dysfunction-Associated Steatotic Liver Disease with Fibrosis

Published on: July 18, 2025

Immunofluorescence to Monitor the Cellular Uptake of Human Lactoferrin and its Associated Antiviral Activity Against the Hepatitis C Virus06:28

Immunofluorescence to Monitor the Cellular Uptake of Human Lactoferrin and its Associated Antiviral Activity Against the Hepatitis C Virus

Published on: October 1, 2015

Related Concept Videos

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow01:26

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug binding...
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...
Cirrhosis II: Pathophysiology01:24

Cirrhosis II: Pathophysiology

Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...
Retrovirus Life Cycles01:10

Retrovirus Life Cycles

Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the retrovirus to...
Cirrhosis I: Introduction01:23

Cirrhosis I: Introduction

Cirrhosis is a chronic, irreversible liver disease characterized by the widespread replacement of healthy liver tissue with fibrotic scar tissue and the formation of regenerative nodules.Etiology of cirrhosisCirrhosis results from sustained liver injury that triggers progressive fibrosis and structural remodeling. The underlying causes are diverse, encompassing common and less frequent clinical conditions. Regardless of the origin, all causes lead to chronic inflammation, hepatocyte loss, and...
Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...